Cas:54902-68-0 1,6-naphthyridine,dihydrochloride manufacturer & supplier

We serve Chemical Name:1,6-naphthyridine,dihydrochloride CAS:54902-68-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1,6-naphthyridine,dihydrochloride

Chemical Name:1,6-naphthyridine,dihydrochloride
CAS.NO:54902-68-0
Synonyms:1,6-naphthyridine,dihydrochloride
Molecular Formula:C8H8Cl2N2
Molecular Weight:203.06900
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:25.78000
Exact Mass:202.00600
LogP:3.23380

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1,6-naphthyridine,dihydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,6-naphthyridine,dihydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,6-naphthyridine,dihydrochloride Use and application,1,6-naphthyridine,dihydrochloride technical grade,usp/ep/jp grade.


Related News: The company-backed investigation was based on interviews with more than 100 people, the May 20 memo to Lilly employees said. However, the memo did not respond to all concerns employees raised in their April complaint, which Reuters reviewed. 1,6-naphthyridine,dihydrochloride manufacturer The main API products include antihypertensive, psychotropic and anti-AIDS special APIs. Antihypertensive APIs are mainly pulic and sartan drugs, and they are the world’s major suppliers of pulic and sartan APIs. 1,6-naphthyridine,dihydrochloride supplier The upstream industry for the R & D, production and sales of pharmaceutical intermediates is the basic chemical raw material industry, and the downstream industry is the chemical bulk drug and chemical pharmaceutical preparation industry. 1,6-naphthyridine,dihydrochloride vendor The company-backed investigation was based on interviews with more than 100 people, the May 20 memo to Lilly employees said. However, the memo did not respond to all concerns employees raised in their April complaint, which Reuters reviewed. 1,6-naphthyridine,dihydrochloride factory The company-backed investigation was based on interviews with more than 100 people, the May 20 memo to Lilly employees said. However, the memo did not respond to all concerns employees raised in their April complaint, which Reuters reviewed.